Boeing is trading higher as investors react to fresh company materials released around late March/April 1 that highlight a new multi-year U.S. defense production framework and reinforce the improving 2026 production-and-deliveries narrative. The market is treating the update as incremental evidence that operational momentum is stabilizing across both defense and commercial programs, supporting the stock after a volatile stretch.

Beyond defense, the tape is leaning into expectations for higher commercial airplane deliveries through 2026 and better execution on widebody programs. Separately, the 777X program has a near-term milestone window with the first flight of a production 777X targeted for April 2026, keeping attention on certification progress and eventual delivery timing—key variables for cash flow and backlog conversion.

Investors are also watching developments around a potential China order that has been discussed publicly in recent weeks, with reports pointing to negotiations for a very large 737 MAX deal potentially timed around high-level U.S.–China meetings running March 31 through April 2, 2026. Even without a signed announcement today, the possibility of a breakthrough order acts as a sentiment catalyst because it would meaningfully extend Boeing’s narrowbody backlog and improve long-duration production visibility.